GlassScriptPhysician profile
Allyson Barker
NPI 1811347479
$1,253.77
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12.45 · 2020: $48.69 · 2021: $102 · 2022: $404 · 2023: $324 · 2024: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $546.66 | 2021-2024 | Vraylar, Qulipta, Ubrelvy |
| Novo Nordisk INC | $190.34 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $76.09 | 2020-2021 | |
| Exact Sciences Corporation | $65.71 | 2023-2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $59.20 | 2024 | Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $41.63 | 2022-2024 | Airsupra, Farxiga |
| Lilly USA, LLC | $40.80 | 2022-2023 | Mounjaro |
| Pfizer INC. | $39.66 | 2022-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.92 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $30.04 | 2019-2022 | |
| Lundbeck LLC | $22.38 | 2024 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.34 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.00 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $16.58 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $15.66 | 2024 | Rexulti |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $15.56 | 2020 | |
| Medtronic, INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Barker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.